Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Pharmacy Language Access Is a Code-Red Patient Safety Problem, RxTran White Paper Warns

      RxTran, a division of Language Scientific, Inc., delivers 100% accurate native-language prescription medication labeling in 26 languages through its patented Transduction technology.

      News provided by

      RxTran

      Oct 06, 2026, 09:58 ET

      Share this article

      Share this article


      Report urges pharmacists and legislators to treat unverified prescription translation as a clinical risk as more states adopt label translation laws

      Key takeaways:

      • RxTran, a division of Language Scientific, released Pharmacy Language Access Is a Code-Red Problem, a white paper finding that pharmacies can comply with every state prescription label law and still dispense labels that patients with limited English proficiency can't read.
      • More than 28 million U.S. residents have limited English proficiency. Five states regulate prescription label translation in different ways, and Washington's rule, effective Jan. 22, 2027, sets no language limit.
      • Every RxTran translation is verified by a licensed bilingual pharmacist. Its library of more than 1 million pre-translated prescription directions passes a five-step quality control review before a translation reaches a patient.

      BOSTON, Oct. 6, 2026 /PRNewswire/ -- RxTran, a division of Language Scientific, today released Pharmacy Language Access Is a Code-Red Problem, a white paper arguing that unverified prescription translation puts patients at risk and that state mandates alone won't fix it. The report draws on peer-reviewed outcomes research, federal patient safety guidance, the five state laws that govern prescription labels, and RxTran's own label-request data.

      The white paper includes contributions from Sharon Blank, Chief Executive Officer of Language Scientific and RxTran, and Kristen Beiers-Jones, RN, MN, Assistant Professor of Clinical Nursing at the Oregon Health & Science University School of Nursing, who led the effort to pass Oregon's prescription label translation law.

      "This should be a wake-up call for pharmacists, pharmacy leaders, legislators, and state boards of pharmacy," said Blank. "Compliance with the law is too low a standard. The right standard is accountable language access, where a qualified professional verifies every translated label and can stand behind it. A patient should walk out of the pharmacy able to safely take their medicine."

      Why is pharmacy language access a code-red problem?
      In 2006, the Institute of Medicine identified poor comprehension of prescription directions as a root cause of adverse drug events. Two decades later, the label still hasn't been made comprehensible for more than 28 million U.S. residents with limited English proficiency. In one study of more than 400,000 hospitalized adults, patients with limited English proficiency had 33% higher odds of readmission within seven days.

      Why isn't complying with state law enough?
      Title VI of the Civil Rights Act and Section 1557 of the Affordable Care Act apply to nearly every hospital and pharmacy in the country. Five states go further and regulate prescription labels directly, but no two require the same languages. Washington's rule, WAC 246-945-029, takes effect Jan. 22, 2027, and requires pharmacies to provide patients access to written translation and oral interpretation support in the 10 most common languages spoken in the state. None of these laws guarantees that the patient can read the label.

      "Since passing the Oregon law, every pharmacy and health system has approached the requirement differently," said Beiers-Jones. The result, she said, is inconsistent implementation with no dedicated funding behind it. "Pharmacists want all patients to understand how to take their medications, but the systems to support pharmacists in this are lacking."

      What does the white paper recommend pharmacies do?
      The report defines accountable language access as a pharmacy's ability to stand behind a translated label clinically and legally, and to name who verified it. Its six principles start with human clinical validation, with a qualified reviewer checking every translation before it reaches a patient, and end with a named party accountable for accuracy.

      How are RxTran's translations validated and delivered?
      RxTran's library holds more than 1 million pre-translated SIGs (the directions for use that appear on a label) across 27 languages. Every one passes a five-step quality control review: a forward translation, an independent edit, a back translation into English, a reconciliation of the back translation against the English source, and final approval by a licensed bilingual pharmacist. RxTran's patented Transduction technology lets a pharmacist confirm the meaning of a translation in English before it reaches the patient.

      RxTran integrates with most major pharmacy software and data partners used across independent and chain pharmacies, including Best Computer Systems, Computer-Rx, Datascan, En-Vision, Foundation Systems, Gold Standard/Elsevier, Liberty Software, PDX Enterprise Pharmacy System, QS/1, Rx30, ScriptPro, Speed Script, and SRS Pharmacy Systems. Pharmacies without an integrated system can reach translations through RxTran's web platform.

      The full white paper, "Pharmacy Language Access Is a Code-Red Problem," is available at: https://www.rxtran.com/wp-content/uploads/2026/10/White-Paper-RxTran_Pharmacy-Language-Access-is-a-Code-Red-Problem.pdf.

      About RxTran
      RxTran is a division of Language Scientific, Inc., the clinical, medical, and scientific language specialists. RxTran's patented Transduction technology (U.S. patents 11,836,454 and 12,602,554) provides pharmacist-verified prescription medication labeling in 27 languages (soon to be 30 languages). For more information visit www.rxtran.com or www.languagescientific.com.

      Media Contact
      [email protected]

      SOURCE RxTran

      Modal title

      Also from this source

      Yiddish Speakers in New York Can Now Get Prescription Labels in Their Own Language

      Yiddish Speakers in New York Can Now Get Prescription Labels in Their Own Language

      Pharmacies serving Yiddish-speaking patients can now print prescription directions in Yiddish. RxTran, a division of Language Scientific, has added...

      RxTran Awarded Second U.S. Patent for Technology That Lets Pharmacists Verify a Translation They Cannot Read

      RxTran Awarded Second U.S. Patent for Technology That Lets Pharmacists Verify a Translation They Cannot Read

      The U.S. Patent and Trademark Office has granted Language Scientific a second patent covering RxTran's Transduction technology, the system that lets...

      More Releases From This Source

      Explore

      Pharmaceuticals

      Pharmaceuticals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Equipment

      Medical Equipment

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.